Clinical Trials Browser

Phase 2 × Lymphoma, Extranodal NK-T-Cell × pembrolizumab × Clear all

Lymphoma, Extranodal NK-T-Cell

NCT03012620 2024-02-28

AcSé

CNSEndocrineGynecologicHead & NeckLymphoidSarcoma

Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Carcinoma, Neuroendocrine, Lymphoma, Extranodal NK-T-Cell

NCT03107962 2017-04-11

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

Phase 2 Unknown

20 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

Clinical Trials

Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma

AcSé

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma